Literature DB >> 22579346

Relation between angiographic lesion severity, vulnerable plaque morphology and future adverse cardiac events (from the Providing Regional Observations to Study Predictors of Events in the Coronary Tree study).

Kyeong Ho Yun1, Gary S Mintz, Naim Farhat, Steven P Marso, Nevio Taglieri, Stefan Verheye, Michael C Foster, M Pauliina Margolis, Barry Templin, Ke Xu, Ovidiu Dressler, Roxana Mehran, Gregg W Stone, Akiko Maehara.   

Abstract

Previous angiographic studies have suggested that the future risk for major adverse cardiovascular events (MACEs) is related to coronary stenosis severity. The aim of this study was to use the grayscale and virtual histology (VH)-intravascular ultrasound (IVUS) data from the Providing Regional Observations to Study Predictors of Events in the Coronary Tree (PROSPECT) study to identify underlying lesion morphologic characteristics that might explain these findings. In PROSPECT, patients presenting with acute coronary syndromes in whom percutaneous coronary intervention was successful underwent 3-vessel grayscale and VH-IVUS and were followed for a median of 3.4 years for the incidence of MACEs. Overall, 3,115 nonculprit lesions detected by IVUS were divided into quartiles according to baseline angiographic diameter stenosis. From the first to fourth quartiles, there were increases in the prevalence of lesions with IVUS minimum luminal areas ≤ 4 mm(2), IVUS plaque burden ≥ 70%, and VH-IVUS thin-cap fibroatheroma (13.4%, 22.0%, 24.2%, and 30.3%, respectively, p <0.001), along with an increased frequency of plaque ruptures and greater necrotic core volumes. The incidence of lesions with plaque burden ≥ 70%, minimum luminal area ≤ 4 mm(2), and VH thin-cap fibroatheroma was highest in the fourth quartile (0%, 0.4%, 0.4%, and 2.8% in the first through fourth quartiles, respectively, p <0.001). Three-year MACE rates were also highest in the fourth quartile (0.3%, 0.7%, 1.3%, and 5.1%, respectively, p <0.001). In conclusion, increasing angiographic diameter stenosis was associated with an increased frequency of grayscale and VH-IVUS lesion morphologic features that have been associated with adverse events and that may, in part, explain why future MACEs were related to baseline lesion severity.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22579346     DOI: 10.1016/j.amjcard.2012.04.018

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

Review 1.  New insights into the vulnerable plaque from imaging studies.

Authors:  Robert S Fenning; Robert L Wilensky
Journal:  Curr Atheroscler Rep       Date:  2014-03       Impact factor: 5.113

2.  Plaque burden can be assessed using intravascular optical coherence tomography and a dedicated automated processing algorithm: a comparison study with intravascular ultrasound.

Authors:  Edouard Gerbaud; Giora Weisz; Atsushi Tanaka; Romain Luu; Hany Ahmed Salaheldin Hussein Osman; Grace Baldwin; Pierre Coste; Laurent Cognet; Sergio Waxman; Hui Zheng; Jeffrey W Moses; Gary S Mintz; Takashi Akasaka; Akiko Maehara; Guillermo J Tearney
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2020-06-01       Impact factor: 6.875

3.  Residual Vein Thrombosis Echogenicity Is Associated to the Risk of DVT Recurrence: A Cohort Study.

Authors:  Bruna M Mazetto; Fernanda L A Orsi; Sandra A F Silveira; Luis F Bittar; Mariane M C Flores-Nascimento; Kiara C S Zapponi; Marina P Colella; Erich V de Paula; Joyce M Annichino-Bizzacchi
Journal:  Clin Appl Thromb Hemost       Date:  2017-04-10       Impact factor: 2.389

4.  Fractional flow reserve or optical coherence tomography guidance to revascularize intermediate coronary stenosis using angioplasty (FORZA) trial: study protocol for a randomized controlled trial.

Authors:  Francesco Burzotta; Antonio Maria Leone; Giovanni Luigi De Maria; Giampaolo Niccoli; Valentina Coluccia; Giancarlo Pirozzolo; Silvia Saffioti; Cristina Aurigemma; Carlo Trani; Filippo Crea
Journal:  Trials       Date:  2014-04-23       Impact factor: 2.279

5.  Fractional flow reserve of non-culprit vessel post-myocardial infarction: is it reliable?

Authors:  Luís Leite; Joana Moura Ferreira; João Silva Marques; Elisabete Jorge; Vítor Matos; Jorge Guardado; João Calisto; Mariano Pego
Journal:  BMC Cardiovasc Disord       Date:  2015-10-14       Impact factor: 2.298

6.  Clinical Outcomes in Patients with Deferred Coronary Lesions according to Disease Severity Assessed by Fractional Flow Reserve.

Authors:  Ki Bum Won; Chang Wook Nam; Yun Kyeong Cho; Hyuck Jun Yoon; Hyoung Seob Park; Hyungseop Kim; Seongwook Han; Seung Ho Hur; Yoon Nyun Kim; Sang Hyun Park; Jung Kyu Han; Bon Kwon Koo; Hyo Soo Kim; Joon Hyung Doh; Sung Yun Lee; Hyoung Mo Yang; Hong Seok Lim; Myeong Ho Yoon; Seung Jea Tahk; Kwon Bae Kim
Journal:  J Korean Med Sci       Date:  2016-12       Impact factor: 2.153

7.  Characteristics Detected on Computed Tomography Angiography Predict Coronary Artery Plaque Progression in Non-Culprit Lesions.

Authors:  Yahang Tan; Jia Zhou; Ying Zhou; Xiaobo Yang; Junjie Yang; Yundai Chen
Journal:  Korean J Radiol       Date:  2017-04-03       Impact factor: 3.500

8.  Long-term outcomes after fractional flow reserve-guided percutaneous coronary intervention in patients with severe coronary stenosis.

Authors:  Ying-Hua Zhang; Jing Li; Andreas J Flammer; Yoshiki Matsuo; Moo-Sik Lee; Ryan J Lennon; Malcolm R Bell; David R Holmes; John F Bresnahan; Charanjit S Rihal; Lilach O Lerman; Amir Lerman
Journal:  J Geriatr Cardiol       Date:  2019-04       Impact factor: 3.327

9.  The Severity of Coronary Arterial Stenosis in Patients With Acute ST-Elevated Myocardial Infarction: A Thrombolytic Therapy Study.

Authors:  Salih Kilic; Umut Kocabas; Levent Hurkan Can; Oguz Yavuzgil; Mehdi Zoghi
Journal:  Cardiol Res       Date:  2018-02-11

10.  Non-culprit plaque characteristics in acute coronary syndrome patients with raised hemoglobinA1c: an intravascular optical coherence tomography study.

Authors:  Shaotao Zhang; Jiannan Dai; Haibo Jia; Sining Hu; Hongwei Du; Ning Li; Yongpeng Zou; Yanan Zou; Shenhong Jing; Yan Wang; Rong Sun; Bo Yu
Journal:  Cardiovasc Diabetol       Date:  2018-06-15       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.